126 related articles for article (PubMed ID: 16797768)
1. Cloning, purification and biochemical characterization of a thrombus-ditargeting thrombolytic agent, comprised of annexin B1, ScuPA-32K and fibrin-adherent peptide.
Ding FX; Yan HL; Lu YM; Xue G; Mei Q; Huang JJ; Zhao ZY; Wang YZ; Sun SH
J Biotechnol; 2006 Nov; 126(3):394-405. PubMed ID: 16797768
[TBL] [Abstract][Full Text] [Related]
2. Construction, expression, and characterization of a recombinant annexin B1-low molecular weight urokinase chimera in Escherichia coli.
Yan HL; Wang WT; He Y; Zhao ZY; Gao YJ; Zhang Y; Sun SH
Acta Biochim Biophys Sin (Shanghai); 2004 Mar; 36(3):184-90. PubMed ID: 15202502
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a recombinant chimeric plasminogen activator consisting of a fibrin peptide and a low molecular mass single-chain urokinase.
Jiao J; Yu M; Ru B
Biochimie; 2001; 83(11-12):1049-55. PubMed ID: 11879733
[TBL] [Abstract][Full Text] [Related]
4. Design and characterization of a platelet-targeted plasminogen activator with enhanced thrombolytic and antithrombotic potency.
Yan HL; Sun SH; Wang WT; Ding FX; Mei Q; Xue G
Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):115-25. PubMed ID: 16965265
[TBL] [Abstract][Full Text] [Related]
5. A novel, cheap and effective fusion expression system for the production of recombinant proteins.
Ding FX; Yan HL; Mei Q; Xue G; Wang YZ; Gao YJ; Sun SH
Appl Microbiol Biotechnol; 2007 Nov; 77(2):483-8. PubMed ID: 17768617
[TBL] [Abstract][Full Text] [Related]
6. Functional properties of a recombinant chimeric plasminogen activator with platelet-targeted fibrinolytic and anticoagulant potential.
Zhang L; Wang J; Yu M; Ru B
Mol Genet Metab; 2004 Aug; 82(4):304-11. PubMed ID: 15308128
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of annexin B1 from Cysticercus cellulosae.
Winter A; Yusof AM; Gao E; Yan HL; Sun SH; Hofmann A
FEBS J; 2006 Jul; 273(14):3238-47. PubMed ID: 16857011
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a recombinant chimeric plasminogen activator composed of Gly-Pro-Arg-Pro tetrapeptide and truncated urokinase-type plasminogen activator expressed in Escherichia coli.
Hua ZC; Chen XC; Dong C; Zhu DX
Biochem Biophys Res Commun; 1996 May; 222(2):576-83. PubMed ID: 8670247
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase.
Hagemeyer CE; Tomic I; Weirich U; Graeber J; Nordt T; Runge MS; Bode C; Peter K
J Thromb Haemost; 2004 May; 2(5):797-803. PubMed ID: 15099287
[TBL] [Abstract][Full Text] [Related]
10. A fusion protein with improved thrombolytic effect and low bleeding risk.
Wang X; Zhang G; Wang L; Zhang Q; Qin Y; Wu C; Yu A
Thromb Haemost; 2009 Dec; 102(6):1194-203. PubMed ID: 19967151
[TBL] [Abstract][Full Text] [Related]
11. A recombinant antibody-targeted plasminogen activator with high affinity for activated platelets increases thrombolytic potency in vitro and in vivo.
Wan H; Liu Z; Xia X; Gu J; Wang B; Liu X; Zhu M; Li P; Ruan C
Thromb Res; 2000 Feb; 97(3):133-41. PubMed ID: 10680644
[TBL] [Abstract][Full Text] [Related]
12. Annexin B1 from Taenia solium metacestodes is a newly characterized member of the annexin family.
Zhang Y; Wang KH; Guo YJ; Lu YM; Yan HL; Song YL; Wang F; Ding FX; Sun SH
Biol Chem; 2007 Jun; 388(6):601-10. PubMed ID: 17552907
[TBL] [Abstract][Full Text] [Related]
13. [Fibrinolytic properties and thrombolytic effect of a novel fibrinolytic enzyme from Streptomyces sp. Y405].
Wang M; Wang J; Shao M; Wang M; Wang Y
Yao Xue Xue Bao; 1998 Jul; 33(7):481-5. PubMed ID: 12016879
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
[TBL] [Abstract][Full Text] [Related]
15. Site-specific, catheter-based thrombolysis: a new technique for treating intracoronary thrombus and thrombus-containing stenosis.
McKay RG
J Invasive Cardiol; 1995; 7 Suppl E():36E-43E. PubMed ID: 10158388
[TBL] [Abstract][Full Text] [Related]
16. Production of biologically active recombinant annexin B1 with enhanced stability via a tagging system.
Zhang Y; Zheng T; Wang Y; Guo Y; Ding F; Fei M; Cui H; Sun S
Appl Microbiol Biotechnol; 2010 Jan; 85(3):605-14. PubMed ID: 19629475
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: an improved fibrinolytic agent targeted to phospholipid-containing thrombi.
Tanaka K; Einaga K; Tsuchiyama H; Tait JF; Fujikawa K
Biochemistry; 1996 Jan; 35(3):922-9. PubMed ID: 8547274
[TBL] [Abstract][Full Text] [Related]
18. Staphylokinase-annexin XI chimera exhibited efficient in vitro thrombolytic activities.
Chiou JF; Woon MD; Cheng SN; Hsu CH; Cherng SC; Hsieh FK; Lin SM; Shiau CY
Biosci Biotechnol Biochem; 2007 May; 71(5):1122-9. PubMed ID: 17485856
[TBL] [Abstract][Full Text] [Related]
19. The thrombolytic effect of miniplasmin in a canine model of femoral artery thrombosis.
Fu J; Ren J; Zou L; Bian G; Li R; Lu Q
Thromb Res; 2008; 122(5):683-90. PubMed ID: 18328540
[TBL] [Abstract][Full Text] [Related]
20. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
Zhang C; Yu A; Yuan B; Dong C; Yu H; Wang L; Wu C
Thromb Haemost; 2008 Feb; 99(2):324-30. PubMed ID: 18278181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
